Altimmune, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 07, 2023 at 07:07 am EST
Altimmune, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.362 million compared to USD 0.002 million a year ago. Net loss was USD 20.67 million compared to USD 23.52 million a year ago. Basic loss per share from continuing operations was USD 0.39 compared to USD 0.48 a year ago.
For the nine months, sales was USD 0.389 million compared to USD 0.042 million a year ago. Net loss was USD 56.81 million compared to USD 63.05 million a year ago. Basic loss per share from continuing operations was USD 1.1 compared to USD 1.37 a year ago.